# LAMIVUDINE
> **ANDA077695** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2016-11-21
## Drug
- **FDA Application Number:** ANDA077695
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMIVUDINE
- **Generic name:** LAMIVUDINE
- **Active ingredients:** LAMIVUDINE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Rising Pharma Holdings, Inc.
- **First approval:** 2016-11-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077695)
---
*AI Analytics · CC0 1.0*